Akari Therapeutics (AKTX) Net Income towards Common Stockholders Growth (5y) (2019 - 2025)
Akari Therapeutics (AKTX) Net Income towards Common Stockholders Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.12% |
| Sep 30, 2025 | -92.72% |
| Jun 30, 2025 | 11.72% |
| Mar 31, 2025 | 5.54% |
| Dec 31, 2024 | 13.58% |
| Sep 30, 2024 | 1.46% |
| Jun 30, 2024 | -4.45% |
| Mar 31, 2024 | -239.93% |
| Dec 31, 2020 | -25.10% |
| Sep 30, 2020 | 65.43% |
| Jun 30, 2020 | -28.74% |
| Mar 31, 2020 | -23.76% |
| Dec 31, 2019 | -47.68% |
| Sep 30, 2019 | -69.43% |
| Jun 30, 2019 | -22.03% |
| Mar 31, 2019 | 14.96% |